Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Auto-immune hepatitis and antiphospholipids].

S Branger1, N Schleinitz, V Veit

  • 1Service de médecine interne du Professeur-Harlé, CHU de La-Conception, 147, boulevard Baille, 13005 Marseille, France. stephanie.branger@ap-hm.fr

La Revue De Medecine Interne
|March 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 and chronic liver disease: results from the 1219 patients French registry.

Scientific reports·2025
Same author

[Health status and quality of life in β-thalassemia adults in Marseille, France].

La Revue de medecine interne·2024
Same author

[High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis].

La Revue de medecine interne·2024
Same author

[IgG4-related disease: A proteiform pathology with frequent chest manifestations].

Revue des maladies respiratoires·2023
Same author

[Hospitalization for infection in patients treated for giant cell arteritis: A single-centre retrospective study].

La Revue de medecine interne·2023
Same author

La Revue de medecine interne·2023

This study found a high frequency (70.8%) of antiphospholipid antibodies in autoimmune hepatitis patients, but no clinical, biological, or histological correlations. Further research is needed to understand this association.

Area of Science:

  • Immunology
  • Hepatology
  • Rheumatology

Context:

  • Autoimmune hepatitis (AIH) is a chronic liver disease with autoimmune origins.
  • The association between AIH and antiphospholipid antibodies (aPLs) is not well-established, with limited previous reports.
  • Antiphospholipid antibodies are associated with an increased risk of thrombosis and pregnancy complications.

Purpose:

  • To determine the frequency of antiphospholipid antibodies in patients with autoimmune hepatitis.
  • To investigate potential correlations between the presence of aPLs and clinical, biological, or histological features of AIH.
  • To compare findings with existing literature on aPLs and AIH.

Summary:

  • A high frequency (70.8%) of antiphospholipid antibodies was detected in 24 AIH patients.

Related Experiment Videos

  • Specific antibodies found include IgG anticardiolipin (ACL), IgM anti-beta2 glycoprotein I (Abeta2GP1), and others.
  • No significant correlations were observed between aPLs and hypergammaglobulinemia, clinical presentation, biological markers, or histological findings in AIH.
  • Four patients had antiphospholipid syndrome, and seven had co-existing systemic lupus erythematosus.

    • Impact:

    • This study highlights a frequent co-occurrence of antiphospholipid antibodies in autoimmune hepatitis.
    • The findings suggest that while aPLs are common in AIH, they may not directly influence disease characteristics or outcomes.
    • Further large-scale, longitudinal studies are recommended to elucidate the clinical significance and potential therapeutic implications of this association.